Spectra Intelligence, April 2006, Pages: 369
?
- Market potential for each of the novelcancertherapeutics in late stage clinical development
- Which new cancertherapeutics are likely to produce the best clinical results
- Which areas of preclinical drug
Business Insights, June 2011, Pages: 187
This report analyzes current and potential world markets for key cancer-based molecular diagnostics, including advances in the field. This report forecasts future growth to 2016. Market segments
Business Insights, Feb 2007, Pages: 105
based on the numbers of patients globally, 2002
Table 3.11: Cancer vaccine pipeline, 2006
Table 3.12: siRNA drug pipeline, 2006 Innovations in Cancer: NovelTherapeutics, New Diagnostics and Future R
TriMark Publications, July 2011, Pages: 214
labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for cancer, the screening, diagnosis and classification of cancer patients
Business Insights, July 2007, Pages: 128
.
- Commercial potential of several rapidly evolving product and technology breakthroughs. Particularly consistent of the market interplay between monoclonal antibodies, targeted therapeutics, novel chemotherapies
TriMark Publications, Sep 2011, Pages: 343
detection and screening tests for diseases such as breast, colon, ovarian and lungcancer. In addition, diagnostic measurement of cancer disease progression is essential to successful disease management
Global Industry Analysts, Inc., Feb 2011, Pages: 682
Diseases 32
Angiogenesis Inhibitors in Dermatology 33
Select Drugs/Therapeutics with Angiogenic Mode of Action
Approved by FDA for Dermatology 33
4. MARKET TRENDS 34
Cancer - The Key Target Indication
Life Science Intelligence, Inc., Jan 2011
tests for prostate, lung, and breast cancers
- In-situ formed hydrogels for radiation oncology and oncologic surgery
- Combines imaging technology and advanced algorithms to assess early embryo
Global Industry Analysts, Inc., Jan 2011, Pages: 804
) (includes corresponding
Graph/Chart)
Typhoid Vaccine
Yellow Fever Vaccines
Need for Additional Vaccines
Therapeutic Vaccines
DNA Holds the Key
Huge Potential for Protein Based Vaccines
Global Industry Analysts, Inc., Oct 2010, Pages: 659
Eyeing Molecular Diagnostics 20
Product Marketing - Key to Commercial Success 21
Integration of Molecular Diagnostics into Therapeutics 21
Molecular Diagnostics - Moving from Centralization
Business Insights, July 2010, Pages: 198
- Highlight some of the key technologies for imaging biomarker development in different research or clinical settings, as well as pivotal technology developments.
- Analysis of the potential for using
John Wiley and Sons Ltd, Nov 2008, Pages: 424
in current and emerging anticancer therapeutics, such as development of resistance to chemotherapy, including the various processes that drive it, and the pharmacological aspects of cancer therapy
Axis Research Mind, Nov 2011, Pages: 615
IN ORDER TO OFFER SUITABLE SOLUTIONS
MIRNA THERAPEUTICS, INC. PUBLISH NEW DATA ON MIR-34 IN INHIBITING THE GROWTH OF CANCER CELLS
BIOCELLS, INC., TO STORE DENTAL PULP STEM CELLS WHICH AIDS IN STIMULATING
Bioseeker, Jan 2007, Pages: 750
this analysis to drive strategic planning decisions in oncology drug development TOP 7 CANCER INDICATIONS
THERAPEUTIC & COMPETITIVE INSIGHTS
1 EXECUTIVE SUMMARY
2 TABLE OF CONTENTS
21 LIST BOXES
22 LIST
Axis Research Mind, Nov 2011, Pages: 730
SOLUTIONS
MIRNA THERAPEUTICS, INC. PUBLISH NEW DATA ON MIR-34 IN INHIBITING THE GROWTH OF CANCER CELLS
BIOCELLS, INC., TO STORE DENTAL PULP STEM CELLS WHICH AIDS IN STIMULATING NEURAL CELLS AND A SOURCE
Axis Research Mind, Nov 2011, Pages: 629
SOLUTIONS
MIRNA THERAPEUTICS, INC. PUBLISH NEW DATA ON MIR-34 IN INHIBITING THE GROWTH OF CANCER CELLS
BIOCELLS, INC., TO STORE DENTAL PULP STEM CELLS WHICH AIDS IN STIMULATING NEURAL CELLS AND A SOURCE
Axis Research Mind, Nov 2011, Pages: 730
SOLUTIONS
MIRNA THERAPEUTICS, INC. PUBLISH NEW DATA ON MIR-34 IN INHIBITING THE GROWTH OF CANCER CELLS
BIOCELLS, INC., TO STORE DENTAL PULP STEM CELLS WHICH AIDS IN STIMULATING NEURAL CELLS AND A SOURCE
Espicom Business Intelligence Ltd, July 2007, Pages: 306
on the development of MI technology?
- What novel drug development initiative at Germany’s Fraunhofer Institute may affect the lungcancer sector?
This report provides real insights:
- For executives working
Axis Research Mind, Nov 2011, Pages: 1148
IS FOCUSED TO STUDY THE CELL THERAPEUTIC PROCESSES IN ORDER TO OFFER SUITABLE SOLUTIONS
MIRNA THERAPEUTICS, INC. PUBLISH NEW DATA ON MIR-34 IN INHIBITING THE GROWTH OF CANCER CELLS
BIOCELLS, INC., TO STORE
